A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer

Published:2013-01 Issue:1S Volume:189 Page:
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Eggener Scott E.¹,Mueller Alex²,Berglund Ryan K.²,Ayyathurai Raj³⁴,Soloway Cindy³,Soloway Mark S.³,Abouassaly Robert⁴,Klein Eric A.⁴,Jones Steven J.⁴,Zappavigna Chris⁵,Goldenberg Larry⁵,Scardino Peter T.²,Eastham James A.²,Guillonneau Bertrand²

Affiliation:

1. University of Chicago, Chicago, Illinois

2. Memorial Sloan-Kettering Cancer Center, New York, New York

3. University of Miami, Miami, Florida

4. Cleveland Clinic Foundation, Cleveland, Ohio

5. University of British Columbia, Vancouver, British Columbia, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Contemporary trends in low risk prostate cancer: risk assessment and treatment;Cooperberg;J Urol,2007

3. Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations;Roemeling;Cancer,2007

4. Delayed versus immediate surgical intervention and prostate cancer outcome;Warlick;J Natl Cancer Inst,2006

5. Active surveillance for early-stage prostate cancer: review of the current literature;Dall'Era;Cancer,2008

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy;Scientific Reports;2024-08-05

2. Modern Active Surveillance in Prostate Cancer: A Narrative Review;Clinical Genitourinary Cancer;2023-02

3. French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease;Progrès en Urologie;2022-11

4. Diagnostic Accuracy of Contemporary Selection Criteria in Prostate Cancer Patients Eligible for Active Surveillance: A Bayesian Network Meta-Analysis;Frontiers in Oncology;2022-01-10

5. Trends and practices for managing low-risk prostate cancer: a SEER-Medicare study;Prostate Cancer and Prostatic Diseases;2021-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3